2-[4-(dimethylamino)-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-7-(4-methylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-[6-(dimethylamino)-3-pyridinyl]-7-(1-methylpiperidin-4-yl)pyrido[1,2-a]pyrimidin-4-one;2-(1,7-dimethylindazol-5-yl)-7-(4-ethylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-7-[3-(trifluoromethyl)piperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one;7-(1-ethyl-3,6-dihydro-2H-pyridin-4-yl)-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrazino[1,2-a]pyrimidin-4-one
C108H118F3N33O5 — CID 160883861
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-(dimethylamino)-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-7-(4-methylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-[6-(dimethylamino)-3-pyridinyl]-7-(1-methylpiperidin-4-yl)pyrido[1,2-a]pyrimidin-4-one;2-(1,7-dimethylindazol-5-yl)-7-(4-ethylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-7-[3-(trifluoromethyl)piperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one;7-(1-ethyl-3,6-dihydro-2H-pyridin-4-yl)-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrazino[1,2-a]pyrimidin-4-one
2-[4-(dimethylamino)-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-7-(4-methylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-[6-(dimethylamino)-3-pyridinyl]-7-(1-methylpiperidin-4-yl)pyrido[1,2-a]pyrimidin-4-one;2-(1,7-dimethylindazol-5-yl)-7-(4-ethylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-7-[3-(trifluoromethyl)piperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one;7-(1-ethyl-3,6-dihydro-2H-pyridin-4-yl)-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrazino[1,2-a]pyrimidin-4-one (PubChem CID 160883861) has the molecular formula C108H118F3N33O5 and a molecular weight of 2015.35 g/mol. Its IUPAC name is 2-[4-(dimethylamino)-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-7-(4-methylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-[6-(dimethylamino)-3-pyridinyl]-7-(1-methylpiperidin-4-yl)pyrido[1,2-a]pyrimidin-4-one;2-(1,7-dimethylindazol-5-yl)-7-(4-ethylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-7-[3-(trifluoromethyl)piperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one;7-(1-ethyl-3,6-dihydro-2H-pyridin-4-yl)-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrazino[1,2-a]pyrimidin-4-one.
Molecular Properties
| Compound Name | 2-[4-(dimethylamino)-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-7-(4-methylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-[6-(dimethylamino)-3-pyridinyl]-7-(1-methylpiperidin-4-yl)pyrido[1,2-a]pyrimidin-4-one;2-(1,7-dimethylindazol-5-yl)-7-(4-ethylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-7-[3-(trifluoromethyl)piperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one;7-(1-ethyl-3,6-dihydro-2H-pyridin-4-yl)-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrazino[1,2-a]pyrimidin-4-one |
|---|---|
| PubChem CID | 160883861 |
| Molecular Formula | C108H118F3N33O5 |
| Molecular Weight | 2015.35 g/mol |
| Exact Mass | 2013.99 |
| IUPAC Name | 2-[4-(dimethylamino)-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-7-(4-methylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-[6-(dimethylamino)-3-pyridinyl]-7-(1-methylpiperidin-4-yl)pyrido[1,2-a]pyrimidin-4-one;2-(1,7-dimethylindazol-5-yl)-7-(4-ethylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-4-one;2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-7-[3-(trifluoromethyl)piperazin-1-yl]pyrido[1,2-a]pyrimidin-4-one;7-(1-ethyl-3,6-dihydro-2H-pyridin-4-yl)-2-(2-methylimidazo[1,2-b]pyridazin-6-yl)pyrazino[1,2-a]pyrimidin-4-one |
| SMILES | CCN1CC=C(c2cn3c(=O)cc(-c4ccc5nc(C)cn5n4)nc3cn2)CC1.CCN1CCN(c2ccc3nc(-c4cc(C)c5c(cnn5C)c4)cc(=O)n3c2)CC1.CN1CCC(c2ccc3nc(-c4ccc(N(C)C)nc4)cc(=O)n3c2)CC1.Cc1cn2nc(-c3cc(=O)n4cc(N5CCN(C)CC5)ccc4n3)cc2c(N(C)C)n1.Cc1cn2nc(-c3cc(=O)n4cc(N5CCNC(C(F)(F)F)C5)ccc4n3)cc2c(C)n1 |
| InChI | InChI=1S/C23H26N6O.C22H26N8O.C21H20F3N7O.C21H21N7O.C21H25N5O/c1-4-27-7-9-28(10-8-27)19-5-6-21-25-20(13-22(30)29(21)15-19)17-11-16(2)23-18(12-17)14-24-26(23)3;1-15-13-30-19(22(23-15)26(2)3)11-18(25-30)17-12-21(31)29-14-16(5-6-20(29)24-17)28-9-7-27(4)8-10-28;1-12-9-31-17(13(2)26-12)7-16(28-31)15-8-20(32)30-10-14(3-4-19(30)27-15)29-6-5-25-18(11-29)21(22,23)24;1-3-26-8-6-15(7-9-26)18-13-27-20(11-22-18)24-17(10-21(27)29)16-4-5-19-23-14(2)12-28(19)25-16;1-24(2)19-6-4-16(13-22-19)18-12-21(27)26-14-17(5-7-20(26)23-18)15-8-10-25(3)11-9-15/h5-6,11-15H,4,7-10H2,1-3H3;5-6,11-14H,7-10H2,1-4H3;3-4,7-10,18,25H,5-6,11H2,1-2H3;4-6,10-13H,3,7-9H2,1-2H3;4-7,12-15H,8-11H2,1-3H3 |
| InChIKey | SNJNHKKDWBHSDG-UHFFFAOYSA-N |
| XLogP | 11.44 |
| TPSA | 347.21 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 149 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2015.35 |
| LogP ≤ 5 | 11.44 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 38 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160883861 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.